Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004979749 | SCV005575315 | uncertain significance | Inborn genetic diseases | 2024-07-05 | criteria provided, single submitter | clinical testing | The c.481G>T (p.G161C) alteration is located in exon 3 (coding exon 3) of the EMILIN1 gene. This alteration results from a G to T substitution at nucleotide position 481, causing the glycine (G) at amino acid position 161 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |